drugset / Trial / NCT00378521

Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon

NCT00378521 ↗

Phase 2 Completed 15 enrolled MediQuest Therapeutics
RandomizedSingle-groupDouble-blindTreatment

Summary

The Purpose of this study is to determine the response to two different strengths of a topical gel containing nitroglycerin in patients with Raynaud's disease.

Timeline

Start
2006-07
Primary completion
—
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject MQX-503 Unknown — Topical

Indications